Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Opportunities and Challenges in Early Breast Cancer: Do PARP Inhibitors Have a Role?

Opportunities and Challenges in Early Breast Cancer: Do PARP Inhibitors Have a Role?

FromKeeping Current


Opportunities and Challenges in Early Breast Cancer: Do PARP Inhibitors Have a Role?

FromKeeping Current

ratings:
Length:
27 minutes
Released:
Jul 30, 2021
Format:
Podcast episode

Description

Dr Curigliano and Dr Loi discuss the latest clinical data regarding the use of PARP inhibitors in early high-risk breast cancer. Credit available for this activity expires: 7/29/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/955496?src=mkm_podcast_addon_955496
Released:
Jul 30, 2021
Format:
Podcast episode

Titles in the series (100)

Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.